methylprednisolone has been researched along with apyrase in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dang, HA; Muls, NG; Sindic, CJ; van Pesch, V | 1 |
| Bai, F; Cao, Y; Che, D; Chen, H; Chen, P; Chen, Z; Cui, J; Delfouneso, D; Geng, L; Gong, S; Gu, X; Huang, B; Huang, W; Lew, AM; Li, D; Li, H; Liang, H; Liu, Y; Lu, B; Ren, L; Si, W; Su, M; Tang, WH; Wang, H; Wang, J; Wang, Y; Xian, H; Xie, J; Xu, B; Xu, Y; Yang, M; Ye, L; Zeng, L; Zhan, Y; Zhang, L; Zhang, T; Zhang, Y; Zhao, J; Zhao, S | 1 |
2 other study(ies) available for methylprednisolone and apyrase
| Article | Year |
|---|---|
Regulation of Treg-associated CD39 in multiple sclerosis and effects of corticotherapy during relapse.
Topics: Administration, Intravenous; Adult; Antigens, CD; Apyrase; Glucocorticoids; Humans; Methylprednisolone; Multiple Sclerosis, Relapsing-Remitting; T-Lymphocytes, Regulatory; Treatment Outcome | 2015 |
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways.
Topics: Antigens, CD; Apyrase; B-Lymphocytes; Cell Death; Cellular Microenvironment; Child; Cohort Studies; Colon; Dendritic Cells; Dipyridamole; Endothelial Cells; Epithelial Cells; Fibroblasts; Gene Expression Regulation; Genetic Predisposition to Disease; Homeostasis; Humans; Immunoglobulin G; Immunologic Memory; Inflammation; Inflammatory Bowel Diseases; Interferon Type I; Intestinal Mucosa; Macrophages; Methylprednisolone; Myeloid Cells | 2019 |